Good prediction of the likelihood for sentinel lymph node metastasis by using the MSKCC nomogram in a German breast cancer population

Annals of Surgical Oncology

Volumn 16, Issue 5, 2009, Pages 1136-1142

  Klar, M ^a   Foeldi, M ^a   Markert, S ^a   Gitsch, G ^a   Stickeler, E ^a   Watermann, D ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NOMOGRAM; PATIENT ASSESSMENT; RECEIVER OPERATING CHARACTERISTIC; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GERMANY; HUMANS; INTERNET; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NOMOGRAMS; SENTINEL LYMPH NODE BIOPSY;

EID: 64249100165     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0399-3     Document Type: Article

References (32)

1. D Krag D Weaver T Ashikaga F Moffat VS Klimberg C Shriver 1998 The sentinel node in breast cancer-a multicenter validation study N Engl J Med. 339 941 946
2. AE Giuliano DM Kirgan JM Guenther DL Morton 1994 Lymphatic mapping and sentinel lymphadenectomy for breast cancer Ann Surg. 220 391 398 discussion 398-401
3. U Veronesi G Paganelli V Galimberti G Viale S Zurrida M Bedoni 1997 Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes Lancet. 349 1864 1867
4. U Veronesi G Paganelli G Viale A Luini S Zurrida V Galimberti 2006 Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study Lancet Oncol. 12 983 990
5. RE Mansel L Fallowfield M Kissin A Goyal RG Newcombe JM Dixon 2006 Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial J Natl Cancer Inst. 9 599 609
6. I Langer U Guller G Berclaz OR Koechli G Schaer MK Fehr 2007 Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients Ann Surg. 245 452 461
7. PL Choong CJ deSilva HJ Dawkins GF Sterrett P Robbins JM Harvey 1996 Predicting axillary lymph node metastases in breast carcinoma patients Breast Cancer Res Treat. 37 135 149
8. AC Voogd JW Coebergh OJ Repelaer van Driel RM Roumen MW van Beek A Vreugdenhil 2000 The risk of nodal metastases in breast cancer patients with clinically negative lymph nodes: a population-based analysis Breast Cancer Res Treat. 62 63 69
9. A Barth PH Craig MJ Silverstein 1997 Predictors of axillary lymph node metastases in patients with T1 breast carcinoma Cancer. 79 1918 1922
10. M Shoup L Malinzak J Weisenberger 1999 Predictors of axillary lymph node metastasis in T1 breast carcinoma Am Surg. 65 748 752 discussion 752-3
11. G Viale S Zurrida E Maiorano G Mazzarol G Pruneri G Paganelli 2005 Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution Cancer. 103 492 500
12. J Caywood RJ Gray J Hentz BA Pockaj 2005 Older age independently predicts a lower risk of sentinel lymph node metastasis in breast cancer Ann Surg Oncol. 12 1061 1065 Epub 2005 Oct 21
13. AE Giuliano RC Jones M Brennan R Statman 1997 Sentinel lymphadenectomy in breast cancer J Clin Oncol. 15 2345 2350
14. SD Nathanson R Slater D Debruyn A Kapke M Linden 2006 Her-2/neu expression in primary breast cancer with sentinel lymph node metastasis Ann Surg Oncol. 13 205 213
15. JL Bevilacqua MW Kattan JV Fey HS Cody III PI Borgen KJ Van Zee 2007 Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation J Clin Oncol. 25 3670 3679 Epub 2007 Jul 30
16. Van Zee KJ, Manasseh DM, Bevilacqua JL, Boolbol SK, Fey JV, Tan LK, et al. A Nomogram for predicting the likelihood of additional nodal metastasis in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003;10:1140-51.
17. Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, et al. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. J Surg Oncol. 2004;85:102-11.
18. Varghese P, Mostafa A, Abdel-Rahman AT, Akberali S, Gattuso J, Canizales A, et al. Methylene blue dye versus combined dye-radioactive tracer technique for sentinel lymph node localisation in early breast cancer. Eur J Surg Oncol. 2007;33:147-52.
19. CM Florkowski 2008 Sensitivity, specificity, receiver-operating characteristic (ROC) curves and likelihood ratios: communicating the performance of diagnostic tests Clin Biochem Rev. 29 Suppl 1 S83 S87
20. Hosmer DW, Lemeshow S. Applied logistic regression, 2nd ed. New York: Wiley; 2000.
21. A Katz BL Smith M Golshan A Niemierko W Kobayashi RA Raad 2008 Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer J Clin Oncol. 26 2093 2098
22. HE Kohrt RA Olshen HR Bermas WH Goodson DJ Wood S Henry 2008 on behalf of the Bay Area SLN Study. New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients BMC Cancer. 8 4 66
23. AC Degnim C Reynolds G Pantvaidya S Zakaria T Hoskin S Barnes 2005 Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram Am J Surg. 190 543 550
24. L Kocsis M Svébis G Boross M Sinkó R Maráz M Rajtár 2004 Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients Am Surg. 70 1019 1024
25. S Alran Y De Rycke V Fourchotte H Charitansky F Laki MC Falcou 2007 Institut Curie Breast Cancer Study Group. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy Ann Surg Oncol. 14 2195 2201
26. M Klar A Jochmann M Foeldi M Stumpf G Gitsch E Stickeler 2008 The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population Breast Cancer Res Treat. 112 523 531
27. LA Lambert GD Ayers F Meric-Bernstam 2007 Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy Ann Surg Oncol. 8 2422 2423
28. MH Cripe LC Beran WC Liang BJ Sickle-Santanello 2006 The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram Am J Surg. 4 484 487
29. G Cserni 2005 Evaluation of sentinel lymph nodes in breast cancer Histopathology. 46 697 706
30. G Cserni I Amendoeira N Apostolikas 2004 Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of questionnaire-based survey by the European Working Gourp for Breast Screening Pathology J Clin Pathol. 57 695 701
31. Perry N, Broeders M, de Wolf C, et al. (editors). European guidelines for quality assurance in mammography screening, 3rd ed. Luxemburg: European Communities; 2001.
32. T Kuehn A Bembenek H Buechels 2005 Sentinel lymph node biopsy in breast cancer. A national concept for the clinical implementation of sentinel lymph node biopsy (SLNB) in breast cancer patients with special regard to quality assurance Cancer. 103 451 461